Longbao Zhu

Prof. Dr. Longbao Zhu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2024 in ACS Nano
Verified
Journal Article
Closed access
CHChengrui Hu
Chengrui Hu
JWJun Wang
Jun Wang
XGXinxing Gao
Xinxing Gao
JXJie Xia
Jie Xia
WLWanzhen Li
Wanzhen Li
LZLongbao Zhu
Longbao Zhu

30 May 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
WZWeiwei Zhang
Weiwei Zhang
ZKZhao Kuang
Zhao Kuang
PSPing Song
Ping Song
WLWanzhen Li
Wanzhen Li
LGLin Gui
Lin Gui
LZLongbao Zhu
Longbao Zhu
Photothermal therapy has been widely used in the treatment of bacterial infections. However, the short photothermal effective radius of conventional nano-photothermal agents makes it difficult to achieve effective photothermal antibacterial activity. Therefore, improving composite targeting can significantly inhibit bacterial growth. We inhibited the growth of Staphylococcus aureus (S. aureus) by using an extremely low concentration of vancomycin (Van) and applied photothermal therapy with molybdenum disulfide (MoS2). This simple method used chitosan (CS) to synthesize fluorescein 5(6)-isothiocyanate (FITC)-labeled and Van-loaded MoS2-nanosheet hydrogels (MoS2-Van-FITC@CS). After modifying the surface, an extremely low concentration of Van could inhibit bacterial growth by trapping bacteria synergistically with the photothermal effects of MoS2, while FITC labeled bacteria and chitosan hydrogels promoted wound healing. The results showed that MoS2-Van-FITC@CS nanosheets had a thickness of approximately 30 nm, indicating the successful synthesis of the nanosheets. The vitro antibacterial results showed that MoS2-Van-FITC with near-infrared irradiation significantly inhibited S. aureus growth, reaching an inhibition rate of 94.5% at nanoparticle concentrations of up to 100 µg/mL. Furthermore, MoS2-Van-FITC@CS could exert a healing effect on wounds in mice. Our results demonstrate that MoS2-Van-FITC@CS is biocompatible and can be used as a wound-healing agent.

8 November 2023 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
WZWeiwei Zhang
Weiwei Zhang
XSXiaokuo Shen
Xiaokuo Shen
WLWanzhen Li
Wanzhen Li
JWJun Wang
Jun Wang
ZKZhao Kuang
Zhao Kuang
LZLongbao Zhu
Longbao Zhu

21 August 2023 in Nanotechnology
Verified
Journal Article
Closed access
XCXiaolu Chen
Xiaolu Chen
PSPing Song
Ping Song
WLWanzhen Li
Wanzhen Li
JWJun Wang
Jun Wang
TGTing Gui
Ting Gui
LZLongbao Zhu
Longbao Zhu
Photodynamic therapy (PDT) has emerged as an efficient strategy for tumor treatment. However, Insufficient amounts of inherent hypoxia and intrinsic hydrogen peroxide (H 2 O 2 ) in the tumor microenvironment severely constrained PDT, as oxygen is the critical substrate for photosensitivity reaction. Here, a pH-responsive H 2 O 2 and O 2 self-supplying hybrid nanoparticle was designed. Through, the calcium peroxide (CaO 2 ) as carriers loading a chemotherapeutic drug a photosensitizer 5,10,15,20-tetrakis(4-aminophenyl) porphyrin (TAPP) and doxorubicin (DOX), was covered with polyacrylic acid (PAA) to build up a feature material DOX-TAPP-CaO 2 @OA@PAA (denoted as DTCOP) through the reverse microemulsion method. In the acidic tumor microenvironment conditions exposing the water-sensitive CaO 2 nanocore to generate hydrogen peroxide (H 2 O 2 ) and O 2 , the self-supplied O 2 alleviates hypoxia to enhance the PDT, and releasing DOX and TAPP. Synthetic characterization shows that the succeeded synthesized Nanocarriers could effectively carry DOX and TAPP to the tumor site and release O 2 at the low pH of TME. And the experimental results demonstrated that this interpose exogenous oxygen strategy is efficient at inhibition of tumor growth both in vitro and in vivo . The nanocomposite exhibits excellent biocompatibility and the ability to inhibit tumor growth and has significant potential for the treatment of hypoxic tumors.

27 July 2025 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
YWYimei Wang
Yimei Wang
XSXuechao Shi
Xuechao Shi
SHShuxian Hou
Shuxian Hou
GYGuoqiang Yang
Guoqiang Yang
XLXinxin Liu
Xinxin Liu
FGFei Ge
Fei Ge

18 March 2025 in Fermentation
Verified
Journal Article
Open access
PDF file
ZLZheng Liu
Zheng Liu
TGTing Gao
Ting Gao
SBShaoheng Bao
Shaoheng Bao
PHPenggang Han
Penggang Han
GYGe Yao
Ge Yao
HJHui Jiang
Hui Jiang
Neo-allo-ocimene is a monoterpene which could be applied in pesticides, fragrances, and sustainable polymers. In this study, we mined a terpene synthase, AgTPS40, from the transcriptome of celery leaf tissues. Through sequence and phylogenetic analysis, AgTPS40 was characterized as a monoterpene synthase. The AgTPS40 gene was introduced into a heterologous mevalonate pathway hosted in Escherichia coli to enable terpene production. Gas chromatography–mass spectrometry analysis confirmed that AgTPS40 catalyzes the formation of neo-allo-ocimene, marking the first reported identification of a neo-allo-ocimene synthase. Subsequently, we optimized the fermentation conditions and achieved a yield of 933.35 mg/L in a 1 L shake flask, which represents the highest reported titer of neo-allo-ocimene to date. These results reveal the molecular basis of neo-allo-ocimene synthesis in celery and provide a sustainable way to obtain this compound.